A UK vaccine site that has received more than £205million of taxpayer cash was today sold off to a US pharmaceutical giant.
The Vaccine Manufacturing and Innovation Centre (VMIC), which is being built near Oxford, was snapped up by New Jersey-headquarted Catalent for an unknown sum.
Campaigners branded the sale “beyond absurd” and “short-sighted” after warnings a worse Covid variant could still emerge.
